(Press-News.org) Summary: The ideal management strategy for primary cardiogenic shock is a matter of debate. After some early discouraging experiences, the use of extracorporeal life support for patients with cardiogenic shock is having a resurgence. A report from researchers in Padua, Italy finds that patients who have an acute onset of cardiogenic shock, for example following a heart attack, and are placed on extracorporeal life support, fare better than those who have a chronic cardiac pathology. In an accompanying editorial, Dr. Vivek Rao of the University of Toronto puts the findings of the study, such as a 59% survival to hospital discharge rate, in perspective.
Beverly, MA, August 20, 2015 - Cardiogenic shock is when a patient's heart is so severely damaged that it is no longer able to pump blood to the organs of the body. When this occurs, mechanical circulatory support may be the only hope for survival. While different options are available, recovery of cardiac function with extracorporeal life support (ECLS) differs dramatically depending upon whether the cardiogenic shock results from an acute episode, such as a heart attack, or chronic cardiac deterioration. The results of a new study are reported in The Journal of Thoracic and Cardiovascular Surgery, the official publication of the American Association for Thoracic Surgery (AATS).
"ECLS is a bridge-to-life and should be considered a first-line treatment in primary cardiogenic shock," explained lead investigator Vincenzo Tarzia, MD, from the Division of Cardiac Surgery (Chief Prof. Gino Gerosa), Department of Cardiac, Thoracic, and Vascular Sciences, Padua University Hospital (Italy). "Therapeutic strategies should be tailored considering the different outcomes with respect to etiology. For those with an acute etiology, short-term ECLS may be the only therapy required."
Dr. Tarzia and colleagues examined the outcomes of 64 patients who received an ECLS device for cardiogenic shock who were refractory to other forms of treatment. Cardiogenic shock had an acute onset in 37 (58%) of cases, with 70% due to an acute myocardial infarction, 11% to myocarditis, 16% to a pulmonary embolism, and 3% to postpartum cardiomyopathy. The investigators compared outcomes in this group to 27 patients who developed cardiogenic shock due to chronic conditions such as dilated cardiomyopathy (74%), ischemic cardiomyopathy (19%), or congenital myopathy (7%).
Investigators found that in the acute group, ECLS was a "bridge-to-recovery" for 18 patients. All of these patients recovered cardiac function and were the only ones in the study to do so, compared with no patients in the chronic group, and this difference was statistically significant. Almost 90% of these patients were alive at the one-year follow-up. In the remainder of the acute etiology group, ECLS was used as a bridge-to-transplantation in three patients and a bridge-to-another bridge (such as a ventricular assist device or total, artificial, longer-term support) in nine patients.
The results were very different for the chronic etiology group, in which 14 patients were bridged to a left ventricular assist device and nine received a heart transplant; no patients in this group were "bridged to recovery."
Thirty-day mortality was higher in the chronic etiology group (26% vs. 16%). No other differences were noted in mortality during ECLS support, hospital discharge, or survival at one-year follow-up.
The investigators also considered how to improve survival for patients placed on ECLS. They found that minimizing the duration of support and maintaining flow rates to about 60% of theoretical requirements offered the best chance of survival.
In an accompanying editorial, Vivek Rao, MD, PhD, of Toronto General Hospital discusses how in recent years ECLS is having a resurgence as a strategy for cardiogenic shock, following initial disappointing experiences with adverse events such as thrombocytopenia, bleeding, and thromboembolic complications. "The newer-generation ECLS circuits, as described in this report, have been proven to be more durable, can be rapidly initiated, and require less systemic anticoagulation than previous circuits. As such, the clinical outcomes of this therapy have improved considerably."
Acute cardiogenic shock is a condition in which the heart cannot pump enough to meet the body's needs. Patients present with critical circulatory instability, requiring immediate treatment. Cardiogenic shock may be precipitated by chronic progressive heart failure, cardiac surgery, or by acute problems such as myocardial infarction, myocarditis, or pulmonary embolism. Conventional treatment may include inotrope infusions, vasopressors, or an intra-aortic balloon pump. ECLS is a type of cardiopulmonary bypass designed for patients who need extended respiratory and/or circulatory support. The ECLS used in the current study was the PLS system (Maquet Cardiopulmonary AG, Hirrlingen Germany).
The results demonstrate that ECLS outcomes significantly depend upon the condition of the heart and timing of the cardiogenic shock. Dr. Rao advised that surgeons should not be discouraged that only 60% of the patients survived to hospital discharge. "All of us who have successfully 'salvaged' a young 40-year-old patient from near certain death would agree that a 60% 'success rate' is still a worthwhile endeavor" - especially since about 80% of these patients achieved long-term survival.
INFORMATION:
Virginia Tech researchers have identified a biomarker in pre-diabetic individuals that could help prevent them from developing Type II diabetes.
Publishing in Clinical Epigenetics, the researchers discovered that pre-diabetic people who were considered to be insulin resistant -- unable to respond to the hormone insulin effectively -- also had altered mitochondrial DNA.
Researchers made the connection by analyzing blood samples taken from 40 participants enrolled in the diaBEAT-it program, a long-term study run by multiple researchers in the Fralin Translational Obesity ...
(BOSTON) - Last year, a Wyss Institute team of scientists described the development of a new device to treat sepsis that works by mimicking our spleen. It cleanses pathogens and toxins from blood circulating through a dialysis-like circuit. Now, the Wyss Institute team has developed an improved device that synergizes with conventional antibiotic therapies and that has been streamlined to better position it for near-term translation to the clinic. The improved design is described in the October volume 67 of Biomaterials.
Sepsis is a common and frequently fatal medical ...
Having a baby at home can save thousands of dollars over a hospital birth and is just as safe for low-risk births, according to a new UBC study.
Researchers with UBC's School of Population and Public Health and the Child and Family Research Institute looked at all planned home births attended by registered midwives in B.C. between 2001 and 2004. They compared them to planned hospital births attended by registered midwives or physicians in which the mothers met the criteria for home birth.
For the first 28 days postpartum, they found planned home births saved an average ...
Amsterdam, August 20, 2015 - A new study published in Journal of Transport & Health reveals that middle-aged drivers are at higher risk of crashes because they use their cellphone regularly while driving. The research reveals that most drivers admit to using their cellphones regularly while driving, even with children in the car; drivers also feel pressured to answer work calls while driving.
The authors of the study, from the University of California San Diego, are now working with companies to teach employees about the risks associated with distracted driving, and show ...
TORONTO, Aug. 20, 2015--A new study has found a "significant association" between adults who have suffered a traumatic brain injury at some point in their lives and who also have attention deficit hyperactive disorder.
The study, published today in the Journal of Psychiatric Research, supports research that found a similar association in children, said Dr. Gabriela Ilie, lead author of the study and a post-doctoral fellow at St. Michael's Hospital.
The data used in the adult study was collected by the Centre for Addiction and Mental Health's Monitor, a continuous, cross-sectional ...
Oxford, August 20, 2015 - Researchers in China have developed tiny nanocrystals that could be used in the next generation of medical imaging technologies to light up cancer cells. In a study published in the inaugural issue of the journal Applied Materials Today, a new rapid, online only publication, the team of researchers describe how they make these films which are based on the heavy metals lanthanum and europium.
Dr. Yaping Du of Xi'an Jiaotong University, China, and colleagues have developed a way to make high-quality nanocrystals of lanthanide oxybromides, where ...
NEW YORK, NY - Patients with scoliosis who undergo surgery may be less likely to develop an infection or other complications after the procedure when a novel wound closure technique pioneered at NYU Langone Medical Center is utilized, according to new research. The study was published online this past July in the Journal of Pediatric Orthopaedics.
In this new technique, surgeons use a multilayered flap closure that enables doctors to close several layers of muscle and fascia while maintaining blood supply from the donor site to the recipient site. The researchers believe ...
Post-discharge disease management provided in their own homes could be a cost-effective alternative for recently-hospitalised elderly patients with chronic heart failure (CHF).
Just published in the International Journal of Cardiology, this is the finding of a recent economic evaluation conducted by Griffith University using data from a randomised controlled trial (The WHICH Study).
In collaboration with the Australian Catholic University, 280 patients with CHF recruited from three public hospitals, received multidisciplinary disease management.
With the aim of reducing ...
The solid waste left over from wine-making could make a competitive biofuel, University of Adelaide researchers have found.
Published in the journal Bioresource Technology, the researchers showed that up to 400 litres of bioethanol could be produced by fermentation of a tonne of grape marc (the leftover skins, stalks and seeds from wine-making).
Global wine production leaves an estimated 13 million tonnes of grape marc waste each year. Nationally it is estimated that several hundred thousand tonnes are generated annually and it is generally disposed of at a cost to ...
The problem has been that the vast majority of these atomically thin 2D crystals are unstable in air, so react and decompose before their properties can be determined and their potential applications investigated.
Writing in Nano Letters, the University of Manchester team demonstrate how tailored fabrication methods can make these previously inaccessible materials useful.
By protecting the new reactive crystals with more stable 2D materials, such as graphene, via computer control in a specially designed inert gas chamber environments, these materials can be successfully ...
